Catalytic differences between porcine blastocyst and placental aromatase isozymes.

Two isozymes of porcine aromatase, the placental and the blastocyst forms, were expressed in CHO cells using the mammalian cell transfection method. Using an 'in-cell' assay (a 3H-water release method), catalytic parameters of the porcine placental aromatase were found to be very similar to those of the human enzyme; however, the activity of the blastocyst isozyme was found to be one-thirtieth that of the placental isozyme. Product isolation assay (using testosterone as the substrate) revealed that the major steroid products were 17beta-estradiol and 19-nortestosterone. The product ratio of estradiol/19-nortestosterone was found to be 94 : 6 for the porcine placental form, 6 : 94 for the porcine blastocyst form, and 92 : 8 for the human wild-type aromatase. Therefore, the porcine blastocyst aromatase isozyme catalyzes mainly androgen 19-desmethylation rather than aromatization. In addition, inhibition profile analyses on the placental and blastocyst isozymes were performed using three steroidal inhibitors [4-hydroxyandro-stenedione (4-OHA), 7alpha-(4'-amino)phenylthio-1, 4-androstandiene-3,17-dione (7alpha-APTADD), and bridge (2, 19-methyleneoxy) androstene-3,17-dione (MDL 101,003)], and four nonsteroidal inhibitors [aminoglutethimide (AG), CGS 20267, ICI D1033, and vorozole (R83842)]. While the two isozymes of porcine aromatase share 93% amino-acid sequence identity, our results indicate that the two porcine aromatase isozymes have distinct responses to various aromatase inhibitors.

[1]  R. Simmen,et al.  Multiple isoforms of porcine aromatase are encoded by three distinct genes , 2000, The Journal of Steroid Biochemistry and Molecular Biology.

[2]  C. Corbin,et al.  Changes in Testosterone Metabolism Associated with the Evolution of Placental and Gonadal Isozymes of Porcine Aromatase Cytochrome P4501. , 1999, Endocrinology.

[3]  J. Gustafsson,et al.  Generation and reproductive phenotypes of mice lacking estrogen receptor beta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Chen,et al.  Aromatase and breast cancer. , 1998, Frontiers in bioscience : a journal and virtual library.

[5]  C. Laughton,et al.  Binding characteristics of aromatase inhibitors and phytoestrogens to human aromatase , 1997, The Journal of Steroid Biochemistry and Molecular Biology.

[6]  R. Simmen,et al.  A developmental switch in expression from blastocyst to endometrial/placental-type cytochrome P450 aromatase genes in the pig and horse. , 1997, Biology of reproduction.

[7]  K. Grandien,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .

[8]  C. Laughton,et al.  Binding characteristics of seven inhibitors of human aromatase: a site-directed mutagenesis study. , 1996, Cancer research.

[9]  R. Simmen,et al.  Molecular cloning of cytochrome P450 aromatase complementary deoxyribonucleic acid from periimplantation porcine and equine blastocysts identifies multiple novel 5'-untranslated exons expressed in embryos, endometrium, and placenta. , 1996, Endocrinology.

[10]  C. Corbin,et al.  Functional ovarian and placental isoforms of porcine aromatase , 1995, Molecular and Cellular Endocrinology.

[11]  E. Simpson,et al.  A three‐dimensional model of aromatase cytochrome P450 , 1995, Protein science : a publication of the Protein Society.

[12]  J. Gaillard,et al.  In vitro 19-norandrogen synthesis by equine placenta requires the participation of aromatase. , 1995, The Journal of endocrinology.

[13]  R. Roberts,et al.  Embryo-uterine interactions in pigs during week 2 of pregnancy. , 2020, Journal of reproduction and fertility. Supplement.

[14]  D. Pompon,et al.  Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening. , 1990, Cancer research.

[15]  M. Glasier,et al.  Formation and metabolism of 5(10)-estrene-3β,17β-diol, a novel 19-norandrogen produced by porcine granulosa cells from C19 aromatizable androgens , 1988 .

[16]  D. Killinger,et al.  The relationship between aromatase activity and body fat distribution , 1987, Steroids.

[17]  L. Kedes,et al.  A human beta-actin expression vector system directs high-level accumulation of antisense transcripts. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Migeon,et al.  Aromatase activity in cultured human genital skin fibroblasts. , 1984, The Journal of clinical endocrinology and metabolism.

[19]  D. Armstrong,et al.  Site of action of androgens on follicle-stimulating hormone-induced aromatase activity in cultured rat granulosa cells. , 1984, Endocrinology.

[20]  D. Armstrong,et al.  Site of androgen inhibition of follicle-stimulating hormone-stimulated progesterone production in porcine granulosa cells. , 1983, Endocrinology.

[21]  P. Siiteri Review of studies on estrogen biosynthesis in the human. , 1982, Cancer research.

[22]  K. Ryan Biochemistry of aromatase: significance to female reproductive physiology. , 1982, Cancer research.

[23]  C. Longcope,et al.  Aromatization of androgens by muscle and adipose tissue in vivo. , 1978, The Journal of clinical endocrinology and metabolism.

[24]  J. Wilson,et al.  Aromatization of androstenedione by cultured human fibroblasts. , 1976, The Journal of clinical endocrinology and metabolism.